CRISPR Therapeutics AG (CRSP)
58.18
+2.19
(+3.91%)
USD |
NASDAQ |
Dec 04, 16:00
58.70
+0.52
(+0.89%)
After-Hours: 20:00
CRISPR Therapeutics Total Assets (Quarterly): 2.245B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 24.86B |
| Intellia Therapeutics, Inc. | 925.28M |
| Novartis AG | 107.29B |
| Beam Therapeutics, Inc. | 1.311B |
| BeOne Medicines Ltd. | 7.633B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 329.33M |
| Shareholders Equity (Quarterly) | 1.916B |
| Debt to Equity Ratio | 0.1101 |
| Current Ratio | 16.22 |
| Net Debt Paydown Yield | 0.07% |